Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs

References

• WHO: fact sheet N204: Hepatitis B. World Health Organization; 2008.
   Google Scholar
• Lok AS, McMahon B. Chronic Hepatitis B: update 2009. Hepatology 2009;50:661–2.
   PubMed Web of Science ®Google Scholar
• Wands JR. Prevention of hepatocellular carcinoma. N Engl J Med 2004;351:1567–70.
   PubMedGoogle Scholar
• Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio PL, Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology 2004;40:883–91.
   PubMed Web of Science ®Google Scholar
• Benyon RC, Iredale JP. Is liver fibrosis reversible? Gut 2000;46:443–6.
   PubMed Web of Science ®Google Scholar
• Bonis PAL, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N Engl J Med 2000;344:452–4.
   Google Scholar
• Dienstag J, Goldin RD, Heathcote EJ, Hann HWL, Wessner M, Stephenson S, Histological outcome during long-term lamivudine therapy. Gastroenterology 2003;124:105–17.
   PubMed Web of Science ®Google Scholar
• Mössner BK, Biagini M, Pedersen C, Christensen PB. Regression of cirrhosis of the liver detected by elastiometry. Scand J Gastroenterol 2008;43:1401–2.
   PubMed Web of Science ®Google Scholar
• Lai C-L, Shouval D, Lok AS, Chang T-T, Cheinquer H, Goodman Z, Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006;354:1011–20.
   PubMed Web of Science ®Google Scholar
• Wu IC, Lai CL, Han SB, Han KH, Gordon S, Chao YC, Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. Hepatology 2010;51:1185–9.
   PubMedGoogle Scholar
• Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010;52:886–93.
   PubMed Web of Science ®Google Scholar
• Yokosuka O, Takaguchi K, Fujioka S, Shindo M, Chayama K, Kobashi H, Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection. J Hepatol 2010;52:791–9.
   PubMed Web of Science ®Google Scholar
• Enomoto M, Mori M, Ogawa T, Fujii H, Kobayashi S, Iwai S, Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression liver stiffness during entecavir therapy. Hepatol Res 2010;40:853–61.
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Ong M-F, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–74.
   PubMed Web of Science ®Google Scholar
• Ganne-Carrié N, Ziol M, de Lédinghen V, Douvin C, Marcellin P, Castéra L, Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511–17.
   PubMed Web of Science ®Google Scholar
• Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V, Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242–7.
   PubMed Web of Science ®Google Scholar
• Sandrin L, Fourquet B, Hasquenoph J-M, Yon S, Fournier C, Mal F, Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Bio 2003;29:1705–13.
   PubMed Web of Science ®Google Scholar
• Krarup H, Andersen S, Madsen PH, Okkels H, Hvingel BH, Laurberg P. Benign course of long-standing hepatitis B virus infection among Greenland Inuit? Scand J Gastroenterol 2008;43:334–43.
   PubMed Web of Science ®Google Scholar
• Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968–73.
   PubMed Web of Science ®Google Scholar
• Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1997;26:1338–42.
   PubMed Web of Science ®Google Scholar
• Vigano M, Massironi S, Lampertico P, Lavarone M, Paggi S, Pozzi R, Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B. Eur J Gastroenterol Hepatol 2010;22:180–4.
   PubMedGoogle Scholar
• Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2009;24:1002–7.
   PubMed Web of Science ®Google Scholar
• Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Vir Hepatit 2007;14:360–9.
   PubMed Web of Science ®Google Scholar
• Schiff ER, Simsek H, Lee WM, Chao Y-C, Sette H, Janssen H, Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis. Am J Gastroenterol 2008;103:2776–83.
   PubMed Web of Science ®Google Scholar
• Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann H-W, Goodman Z, Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999;341:1256–63.
   PubMed Web of Science ®Google Scholar
• Lai CL, Chien RN, Leung N, Chang TT, Guan R, Tai DI, A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61–8.
   PubMed Web of Science ®Google Scholar
• Gish RG, Lok AS, Chang TT, de Man RA, Gadana A, Sollano J, Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. Gastroenterology 2007;133:1437–44.
   PubMed Web of Science ®Google Scholar
• Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422–7.
   PubMed Web of Science ®Google Scholar
• Rodella A, Galli C, Terlenghi L, Perandin F, Bonfanti C, Manca N. Quantitative analysis of HBsAg, IgM anti HBc and anti HBc avidity in acute and chronic hepatitis B. J Clin Vir 2006;37:206–12.
   PubMed Web of Science ®Google Scholar
• Liaw YF, Sung J, Chow WC, Farrell G, Lee CZ, Yuen H, Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351:1521–31.
   PubMed Web of Science ®Google Scholar